<?xml version="1.0"?>
<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dc="http://purl.org/dc/elements/1.1/"><rdf:Description rdf:about="https://dirros.openscience.si/IzpisGradiva.php?id=16142"><dc:title>Pomen PIK3CA aktivirajočih mutacij za izid bolezni pri bolnicah z invazivnim lobularnim karcinomom dojke, zdravljenih z dopolnilno endokrino terapijo</dc:title><dc:creator>Ribnikar,	Domen	(Avtor)
	</dc:creator><dc:creator>Jerič Horvat,	Valentina	(Avtor)
	</dc:creator><dc:creator>Ratoša,	Ivica	(Avtor)
	</dc:creator><dc:creator>Veitch,	Zachary	(Avtor)
	</dc:creator><dc:creator>Grčar-Kuzmanov,	Biljana	(Avtor)
	</dc:creator><dc:creator>Novaković,	Srdjan	(Avtor)
	</dc:creator><dc:creator>Langerholc,	Erik	(Avtor)
	</dc:creator><dc:creator>Pohar Perme,	Maja	(Avtor)
	</dc:creator><dc:creator>Amir,	Eitan	(Avtor)
	</dc:creator><dc:creator>Šeruga,	Boštjan	(Avtor)
	</dc:creator><dc:subject>onkologija</dc:subject><dc:subject>rak dojke</dc:subject><dc:subject>kemoterapija</dc:subject><dc:publisher>Onkolološki inštitut </dc:publisher><dc:date>2022</dc:date><dc:date>2023-01-27 09:28:11</dc:date><dc:type>Neznano</dc:type><dc:identifier>16142</dc:identifier><dc:language>sl</dc:language><dc:rights>by Authors</dc:rights></rdf:Description></rdf:RDF>